INTS vs CURX
Comparison between Intensity Therapeutics Inc (INTS, Company) and Curanex Pharmaceuticals Inc (CURX, Company).
Both INTS and CURX are from the Healthcare sector.
INTS vs CURX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
INTS
$9.50M
Winner
CURX
$9.50M
Max Drawdown
INTS
98.53%
Winner
CURX
97.07%
Sharpe Ratio
Winner
INTS
0.53
CURX
-0.92
5Y Beta
Winner
INTS
-0.44
CURX
1.31
Industry
INTS
Biotechnology
CURX
Biotechnology
P/E Ratio
INTS
-0.63
Winner
CURX
-1.31
Debt to Equity
INTS
0.00%
CURX
0.00%
Free Cash Flow Yield
INTS
-95.46%
CURX
N/A
P/B Ratio
INTS
1.01
CURX
N/A
INTS vs CURX - Historical Returns
Returns include dividend reinvestment.
1M
INTS
-19.76%
Winner
CURX
+11.37%
3M
INTS
-43.37%
Winner
CURX
-17.79%
6M
INTS
-64.99%
Winner
CURX
-11.84%
1Y
Winner
INTS
-48.58%
CURX
-91.67%
Max(CAGR)
Winner
INTS
-71.31%
CURX
-95.39%
INTS vs CURX - Annual Returns (2023 - 2026)
Returns include dividend reinvestment.
| Year | INTS | CURX |
|---|---|---|
| 2026 | -63.88% | -9.04% |
| 2025 | -76.56% | -91.78% |
| 2024 | -79.70% | N/A |
| 2023 | +43.79% | N/A |
INTS vs CURX Drawdown Comparison
The maximum drawdown for INTS was -98.53%, occurring on Jun 12, 2026. This drawdown has not yet recovered.
The maximum drawdown for CURX was -97.07%, occurring on Feb 5, 2026. This drawdown has not yet recovered.
The current INTS drawdown is -98.51%. The current CURX drawdown is -96.34%.
| Rank | INTS | CURX |
|---|---|---|
| #1 | -98.53% Dec 13, 2023 - Jun 12, 2026 | -97.07% Sep 16, 2025 - Feb 5, 2026 |
| #2 | -67.49% Jul 18, 2023 - Dec 8, 2023 | -1.92% Sep 12, 2025 - Sep 16, 2025 |
| #3 | -8.87% Jul 3, 2023 - Jul 18, 2023 | -1.77% Sep 9, 2025 - Sep 11, 2025 |
Correlation
Correlation between INTS and CURX is -0.04 which considered as a very weak or no correlation - the stocks move independently of each other.
-0.04
-101
Select Stocks to Compare
Popular: INTS vs SPYCURX vs SPY
More Comparisons
Compare with similar stocks